相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Solid dispersion of praziquantel enhanced solubility and improve the efficacy of the schistosomiasis treatment
Carine Santana Ferreira Marques et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2018)
Praziquantel Interaction with Mammalian Targets in the Spotlight
Tim A. Day et al.
TRENDS IN PARASITOLOGY (2018)
Innovation in neglected tropical disease drug discovery and development
Hong-Bo Weng et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
M. Danaei et al.
PHARMACEUTICS (2018)
Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads
Gordana Panic et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Schistosomiasis
Donald P. McManus et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Montmorillonite nanoclay as a multifaceted drug-delivery carrier: A review
Sarvaiya Jayrajsinh et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2017)
Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery
Poovi Ganesan et al.
SUSTAINABLE CHEMISTRY AND PHARMACY (2017)
Zeta potential measurements for non-spherical colloidal particles - Practical issues of characterisation of interfacial properties of nanoparticles
R. R. Retamal Marin et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2017)
Nanotechnology as a potential therapeutic alternative for schistosomiasis
Fernanda Tomiotto-Pellissier et al.
ACTA TROPICA (2017)
Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci
Luciana Damacena Silva et al.
ACTA TROPICA (2016)
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation
Slavomira Doktorovova et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Preclinical pharmacokinetic evaluation of praziquantel loaded in poly (methyl methacrylate) nanoparticle using a HPLC-MS/MS
Mayara Malhado et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies
Malgorzata Geszke-Moritz et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: Assay in adult worms and oviposition
Tarsila Ferraz Frezza et al.
ACTA TROPICA (2015)
Praziquantel in a Clay Nanoformulation Shows More Bioavailability and Higher Efficacy against Murine Schistosoma mansoni Infection
Gina S. El-Feky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
Katharina Maisel et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanostructured Lipid Carriers as a Strategy to Improve the In Vitro Schistosomiasis Activity of Praziquantel
Fernanda Kolenyak-Santos et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
Antonio Pinto-Almeida et al.
PLOS ONE (2015)
Insoluble drug delivery strategies: review of recent advances and business prospects
Sandeep Kalepu et al.
ACTA PHARMACEUTICA SINICA B (2015)
In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment
Ana Luiza Ribeiro de Souza et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Schistosomiasis control: praziquantel forever?
Donato Cioli et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2014)
Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
Jennifer Keiser et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis-A Meta-analysis of Comparative and Non-comparative Clinical Trials
Julien Zwang et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Liposomal-praziquantel: Efficacy against Schistosoma mansoni in a preclinical assay
Tarsila Ferraz Frezza et al.
ACTA TROPICA (2013)
A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs
Bhandari Rohit et al.
CURRENT NANOSCIENCE (2013)
Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice
Naglaa El-Lakkany et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2012)
The answer is 17 years, what is the question: understanding time lags in translational research
Zoe Slote Morris et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2011)
Resolution of Praziquantel
Michael Woelfle et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel
Ravi S. Kasinathan et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2010)
Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax
Soheila Kheradmandnia et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Manifesto'' for Advancing the Control and Elimination of Neglected Tropical Diseases
Peter J. Hotez et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Physicochemical Characteristics, Cytotoxicity, and Antioxidant Activity of Three Lipid Nanoparticulate Formulations of Alpha-lipoic Acid
Uracha Ruktanonchai et al.
AAPS PHARMSCITECH (2009)
An update on P-glycoprotein and drug resistance in Schistosoma mansoni
Catherine E. James et al.
TRENDS IN PARASITOLOGY (2009)
Schistosomiasis in Africa: An Emerging Tragedy in Our New Global Health Decade
Peter J. Hotez et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities
Sanaa S. Botros et al.
JOURNAL OF PARASITOLOGY (2006)
TOXICITY ASSESSMENT OF MONTMORILLONITE AS A DRUG CARRIER FOR PHARMACEUTICAL APPLICATIONS: YEAST AND RATS MODEL
Yuan-Haun Lee et al.
BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS (2005)
Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates
D Cioli et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet
MC Wiles et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2004)
Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d'Ivoire
G Raso et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2004)
Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections
S William et al.
PARASITOLOGY (2001)
Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection
J Utzinger et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)
Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art
RH Müller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
分享论文
